Anti-Human Bfl-1 (CT)

Leinco Technologies
Product Code: LEI-B453
Product Group: Primary Antibodies
CodeSizePrice
LEI-B453-20ug20 ug£199.00
Quantity:
LEI-B453-0.1mg0.1 mg£591.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Application: Western Blot (WB)
Shipping:
Ambient
Storage:
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage aliquot in working volumes without diluting and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.

Images

1 / 1

Further Information

Concentration:
0.5 mg/ml
Conjugate/Tag/Label:
Purified No Carrier Protein
Format:
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Formulation:
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Immunogen:
PN:B484
Long Description:
Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells and is caused by caspase activation. Proteins that comprise the Bcl-2 family appear to control the activation of these enzymes. One such member is multi-domain antiapoptotic protein Bfl-1, which is overexpressed in stomach and other cancers. Bfl-1 can interact with Bax and suppress apoptosis by inhibiting the release of cytochrome c and caspase-3 activation. It is upregulated in cisplatin-resistant human bladder tumor, suggesting that its expression may be important for cisplatin resistance and inhibition of apoptosis in cancer cells. At least two isoforms of Bfl-1 are known to exist. Presumably due to post-translational modifications, Bfl-1 is often observed at higher molecular weight in SDS-PAGE than its predicted molecular weight would suggest.
Target:
Bfl-1

References

1. Lockshin, RA. et al. (2000) Cell Death Differ. 7:2-7. 2. Choi, SS. et al. (1995) Oncogene 11:1693-8. 3. Kim, JK. et al. (2004) Cancer Lett. 212:61-70. 4. Zhang, H. et al. (2000) J. Biol. Chem. 275:11092-9

Related Products

Product NameProduct CodeSupplier 
Bfl-1 (CT) Blocking PeptideLEI-B484Leinco Technologies Summary Details
Bfl-1 (NT) Blocking PeptideLEI-B485Leinco Technologies Summary Details